The Path to Unified Clinical: The Idorsia Story | Veeva
Summary
The Path to Unified Clinical: The Idorsia Story After its founding in 2017, Idorsia Pharmaceuticals found itself in a unique position – needing to design and implement a new clinical systems landscape from the ground up. “We started with a clean piece of paper, which is a once in a lifetime opportunity,” says Idorsia’s Associate Director of Clinical and Quality Systems Simone Mechler, “We had a clear strategy and knew that a single platform approach would best support our needs for speed, usability, and compliance.” Prior to implementing Veeva Vault Clinical Suite, Idorsia had a patchwork of individual systems that made it difficult for study teams to work efficiently. It added time, effort, and complexity to running trials.” With Vault CTMS and eTMF, Idorsia has unified its clinical systems and processes. Study teams log into one system across their clinical processes, streamlining workflows and improving productivity. “We wouldn’t have managed the timelines and the scope if we hadn’t gone for a unified suite approach,” continues Simone, “It allowed us to get up to speed very quickly.